Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-17 | Wendy L. Dixon, Ph.D. served as Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb Company from December 2001 until May 2009 and served on the Chief Executive Officer's Executive Committee. From 1996 to 2001 she was Senior Vice President, MarketingUSHH at Merck & Co., Inc., and prior to that she held executive management positions at West Pharmaceuticals, Osteotech, Inc. and Centocor, Inc. and various positions at SmithKline & French Pharmaceuticals in marketing, regulatory affairs, project management and as a biochemist. Dr. Dixon is currently a director of Alkermes Public Limited Company, bluebird bio, Inc., Eleven Biotherapeutics, Inc., and Voyager Therapeutics, Inc. Dr. Dixon was a director of Ardea Biosciences, Inc. from April 2011 until its acquisition in June 2012, a director of DENTSPLY International Inc. from July 2005 until July 2010, a director of Furiex Pharmaceuticals, Inc. from June 2010 until its acquisition in July 2014, and a director of Orexigen Therapeutics, Inc. from April 2010 until January 2016. |
| 2018-03-14 | Wendy L. Dixon, Ph.D. Former Chief Marketing Officer and President, Global Marketing Bristol-Meyers Squibb Company Director since 2010 Age 62 Independent Director Committees Audit Nominating & Corporate Governance Dr. Dixon served as Chief Marketing Officer and President, Global Marketing for Bristol Myers Squibb Company. |
| 2019-03-21 | Dr. Dixon served as Chief Marketing Officer and President, Global Marketing for Bristol Myers Squibb Company from December 2001 until May 2009 and served on the Chief Executive Officer's Executive Committee. |
| 2020-04-20 | Wendy L. Dixon, Ph.D. INDEPENDENT DIRECTOR Age: 64 COMMITTEES: Audit and Finance DIRECTOR SINCE: 2010 Dr. Dixon served as Chief Marketing Officer and President, Global Marketing for Bristol Myers Squibb Company. |
| 2021-04-16 | Dr. Dixon served as Chief Marketing Officer and President, Global Marketing for Bristol Myers Squibb Company from December 2001 until May 2009 and served on the Chief Executive Officer's Executive Committee. |
| 2022-04-29 | Dr. Wendy L. Dixon is retiring from the Board as of the Annual Meeting. Former Chief Marketing Officer and President, Global Marketing Bristol-Myers Squibb Company. The Board has concluded that Wendy L. Dixon should serve on the Board because she has significant corporate marketing and commercial experience in the pharmaceutical industry. She also brings valuable experience in corporate governance and public company board service. Committee Membership: Audit and Finance. 2021 Director Compensation Table shows compensation. |
Data sourced from SEC filings. Last updated: 2026-02-03